1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. Peijia Medical Limited
  6. Summary
    9996   KYG6981F1090

PEIJIA MEDICAL LIMITED

(9996)
  Report
Delayed Hong Kong Stock Exchange  -  04:08 2022-07-05 am EDT
7.600 HKD   -2.94%
06/17Peijia Medical Limited Announces Executive Changes
CI
06/09China Grants Registration, Marketing Approval to Peijia Medical's Balloon Guide Catheter
MT
06/08Peijia Medical Limited Receives NMPA Approval for Registration Application of Fluxcap Balloon Guide Catheter
CI
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Hong Kong Stock Exchange
06/28/2022 06/29/2022 06/30/2022 07/04/2022 07/05/2022 Date
8.22(c) 7.69(c) 7.76(c) 7.83(c) 7.6(c) Last
1 000 000 1 128 000 1 005 000 1 051 000 1 035 000 Volume
+1.36% -6.45% +0.91% +0.90% -2.94% Change
More quotes
Estimated financial data (e)
Sales 2022 323 M 48,2 M 48,2 M
Net income 2022 -396 M -59,1 M -59,1 M
Net cash position 2022 1 737 M 259 M 259 M
P/E ratio 2022 -11,2x
Yield 2022 -
Sales 2023 577 M 86,1 M 86,1 M
Net income 2023 -223 M -33,3 M -33,3 M
Net cash position 2023 1 462 M 218 M 218 M
P/E ratio 2023 -19,6x
Yield 2023 -
Capitalization 4 363 M 651 M 651 M
EV / Sales 2022 8,13x
EV / Sales 2023 5,03x
Nbr of Employees 629
Free-Float 64,6%
More Financials
Company
Peijia Medical Ltd is a China-based holding company mainly engaged in the research and development of interventional procedural medical devices. Through its subsidiaries, the Company operates two segments. Transcatheter Valve Therapeutic Business segment is mainly engaged in the development of transcatheter valve therapeutic medical devices. Neurointerventional Business segment is engaged in the research and... 
More about the company
Ratings of Peijia Medical Limited
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about PEIJIA MEDICAL LIMITED
06/17Peijia Medical Limited Announces Executive Changes
CI
06/09China Grants Registration, Marketing Approval to Peijia Medical's Balloon Guide Cathete..
MT
06/08Peijia Medical Limited Receives NMPA Approval for Registration Application of Fluxcap B..
CI
05/23China Grants Registration, Marketing Approval to Peijia Medical's Balloon Catheter
MT
05/22Peijia Medical Limited Receives NMPA Approval for Registration Application of Fastunnel..
CI
05/22Peijia Medical Limited Receives the Approval from the National Medical Products Adminis..
CI
03/31Peijia Medical Limited Reports Earnings Results for the Full Year Ended December 31, 20..
CI
02/17Chinese Regulators OK Peijia Medical's Registration Application for Blood Clot Removal ..
MT
02/16Peijia Medical Limited Receives the Approval from the National Medical Products Adminis..
CI
01/26Peijia Medical's Revenue Soars 253% to $22 Million in 2021
MT
01/26Peijia Medical Limited Announces Unaudited Group Revenue Results for the Year Ended Dec..
CI
01/19Peijia Medical Obtained Exclusive License for JenaValve's Trilogy TAVR System for Treat..
PR
01/19Peijia Medical Obtained Exclusive License for JenaValve's Trilogy TAVR System for Treat..
CI
01/16Peijia Wins License to Develop, Market Aortic Regurgitation, Stenosis Treatment in Grea..
MT
2021ELON MUSK : Stock Futures Hover After Fresh Wall Street Records
DJ
More news
News in other languages on PEIJIA MEDICAL LIMITED
06/17Peijia Medical Limited annonce des changements de direction
06/08Peijia Medical Limited reçoit l'approbation de la NMPA pour la demande d'enregistrement..
05/22Peijia Medical Limited reçoit l'approbation de la NMPA pour l'application d'enregistrem..
05/22Peijia Medical Limited reçoit l'approbation de l'Administration nationale des produits ..
03/31Peijia Medical Limited annonce ses résultats financiers pour l'année complète se termin..
More news
Chart PEIJIA MEDICAL LIMITED
Duration : Period :
Peijia Medical Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PEIJIA MEDICAL LIMITED
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 3
Last Close Price 6,49 CNY
Average target price 12,22 CNY
Spread / Average Target 88,3%
EPS Revisions
Managers and Directors
Yi Zhang Chairman, Chief Executive & Technology Officer
Leo Tsai Chief Financial Officer
Jian Fong Tan Vice President-Advanced Technology
Kong Rong Pan Chief Operating Officer
Robert Ralph Parks Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
PEIJIA MEDICAL LIMITED-42.86%671
STRYKER CORPORATION-23.77%77 090
SMITH & NEPHEW PLC-11.94%12 032
INSPIRE MEDICAL SYSTEMS, INC.-17.78%5 219
AXONICS, INC.3.50%2 728
DOUBLE MEDICAL TECHNOLOGY INC.-21.75%2 443